@article{bed70c7305474228b5dec5b420b1350c,
title = "Letter to the Editor Regarding: A Comprehensive Review on Copemyl {\textregistered}",
keywords = "Equivalence, Follow-on glatiramer acetate, Glatiramer acetate, Multiple sclerosis",
author = "Giancarlo Comi and Ferdinando Nicoletti and Canonico, \{Pier Luigi\} and Diego Centonze",
note = "Funding Information: Disclosures. Prof. Giancarlo Comi has received in the past year personal compensation for consulting services and/or speaking activities from Teva, Novartis, Sanofi Genzyme, Merck Serono, Biogen, Roche, Almirall, Cel-gene, Forward Pharma, Medday. Prof. Ferdi-nando Nicoletti has received in the last 3 years consultancy fees from Biogen, Lundbeck, Novartis, Alfa-Sigma, FB-Health, Roche, Otsuka, Janssen, and Teva. Prof. Pier Luigi Canonico has received in the last 3 years honoraria, consultancy fees or paid testimony from AbbVie, Amgen, Amicus Therapeutics, Angelini, Astra Zeneca, Biogen, Biomarin, Boheringer Ingel-heim, Celgene, CSL-Behring, Daiichi Sankyo, Eli Lilly, Incyte Biosciences, Intercept, Jazz Pharmaceuticals, Laboratoire CTRS, Leo Pharma, Lundbeck, Menarini, Merck, MSD, Novo Nordisk, Otsuka, Roche, Sage Therapeutics, Sanofi, Shire, Takeda, Tesaro, Teva, UCB. Prof. Diego Centonze is an Advisory Board member of Almirall, Bayer Schering, Biogen, GW Pharmaceuticals, Merck Serono, Novartis, Roche, Sanofi-Genzyme, Teva and received honoraria for speaking or consultation fees from Almirall, Bayer Schering, Biogen, GW Pharmaceuticals, Merck Serono, Novartis, Roche, Sanofi-Gen-zyme, Teva. He is also the principal investigator in clinical trials for Bayer Schering, Biogen, Merck Serono, Mitsubishi, Novartis, Roche, Sanofi-Genzyme, Teva. His preclinical and clinical research was supported by grants from Bayer Schering, Biogen Idec, Celgene, Merck Serono, Novartis, Roche, Sanofi-Genzyme and Teva.",
year = "2018",
month = dec,
day = "1",
doi = "10.1007/s40120-018-0115-y",
language = "English",
volume = "7",
pages = "385--390",
journal = "Neurology and Therapy",
issn = "2193-8253",
publisher = "Adis",
number = "2",
}